OptiBiotix Health (LON:OPTI) Reaches New 52-Week Low – Here’s What Happened

OptiBiotix Health Plc (LON:OPTI) reached a new 52-week low during trading on Monday . The company traded as low as GBX 5.10 and last traded at GBX 5.96, with a volume of 1488455 shares trading hands. The stock had previously closed at GBX 6.16.

OptiBiotix Health Price Performance

The stock has a market cap of £6.28 million, a P/E ratio of -202.50 and a beta of 1.71. The company has a fifty day moving average of GBX 6.87 and a 200 day moving average of GBX 8.64.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.